Saturday, July 11, 2026

Drug profile · INN

vinorelbine

vinorelbine (VINORELBINE EBEWE) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 23
News articles 0
Drug details — vinorelbine

Quick answer

vinorelbine (VINORELBINE EBEWE) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.

Key facts

INN vinorelbine
Brand VINORELBINE EBEWE
Mechanism Tubulin inhibitor

Mechanism of action

Tubulin inhibitor

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 2022-009 Phase 3 · Ningbo Cancer Hospital · metastatic breast cancer
  2. BO40336 Phase 3 · HOFFMANN-LA ROCHE · Completely resected, Stage Ib (tumors ≥ 4 cm) to Stage IIIa,
  3. D9268C00001 Phase 3 · AstraZeneca · "Inoperable or Metastatic Hormone Receptor-Positive, HER2-Ne
  4. D926TC00001 Phase 3 · AstraZeneca · Stage I adenocarcinoma non-small cell lung cancer (NSCLC) wi
  5. DLY201619 Phase 3 · Chinese Academy of · Non-small Cell Lung Cancer Stage IIIA
  6. GO29527 Phase 3 · HOFFMANN-LA ROCHE · Non−Small Cell Lung Cancer
  7. JZP598-303 Phase 3 · Jazz Pharmaceuticals Ireland · Metastatic HER2-positive breast cancer
  8. MK-2870-020 Phase 3 · MSD Merck Sharp · Recurrent or metastatic cervical cancer that has progressed

Frequently asked questions

What is vinorelbine?

vinorelbine (VINORELBINE EBEWE) is a tubulin inhibitor. Associated with Lacuna Pharma Pty Ltd.

What is the brand name for vinorelbine?

VINORELBINE EBEWE is a marketed brand name for vinorelbine. Check FDA Drugs@FDA for the current US label holder and prescribing information.